Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

P silocybin—the psychedelic ingredient found in some “magic” mushrooms—has shown a lot of promise for treating depression and ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help reduce depressive symptoms in people with bipolar II disorder who have not ...

Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

For the first time, a scientific study has examined Oregon's pioneering model for psilocybin therapy, reflecting on a program now two years underway. Psilocybin is the psychedelic compound that occurs ...

(CNN) — Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found.

Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019, according to a new study led by researchers at the ...